Have a personal or library account? Click to login
Relation of Endothelial Dysfunction and Adipokines Levels to Insulin Resistance in Metabolic Syndrome Patients Cover

References

  1. Alberti, K.G., Zimet, P., Shaw J. (2005). The metabolic syndrome — a new worldwide definition. Lancet, 366(9491), 1059-1062.
  2. Antonios, T.F., Singer, D.R., Markandu, N.D., Mortimer, P.S., MacGregor, G.A. (1999). Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension, 34(4 Pt 1), 655-658.10.1161/01.HYP.34.4.655
  3. Bilgili, S., Celebiler, A.C., Dogan, A., Karaca, B. (2008). Inverse relationship between adiponectin and plasminogen activator inhibitor-1 in metabolic syndrome patients. Endocr. Regul., 42(2-3), 63-68.
  4. Bonora, E., Targher, G., Alberiche, M., Bonadonna, R.C., Saggiani, F., Zenere, M.B., Monauni, T., Muggeo, M. (2000). Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care, 23(1), 57-63.10.2337/diacare.23.1.5710857969
  5. Bruun, J.M., Lihn, A.S., Madan, A.K., Pedersen, S.B., Schiøtt, K.M., Fain, J.N., Richelsen, B. (2004). Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue. Amer. J. Physiol. Endocrinol. Metab., 286(1), E8-E13.
  6. Bruun, J, M, Verdich, C., Toubro, S., Astrup, A., Richelsen, B. (2003). Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men. Eur. J. Endocrinol., 148(5), 535-542.
  7. Cha, S.H., Lee, J.K., Lee, J.Y., Kim, H.T., Ryu, H.J., Han, B.G., Kim, J.W., Oh, B., Kimm, K., Shin, H.D., Park, B.L., Park, S., Park, H.Y., Jang. Y. (2007). Association of CCR2 polymorphisms with the number of closed coronary artery vessels in coronary artery disease. Clin. Chim. Acta, 382(1-2), 129-133.10.1016/j.cca.2007.03.01717482150
  8. Charo, I.F., Taubman, M.B. (2004). Chemokines in the pathogenesis of vascular disease. Circ. Res., 95, 858-66.10.1161/01.RES.0000146672.10582.1715514167
  9. Clark, M.G., Wallis, M.G., Barrett, E.J., Vincent, M.A., Richards, S.M., Clerk, L.H., Rattigan, S. (2003). Blood flow and muscle metabolism: A focus on insulin action. Am. J. Physiol. Endocrinol. Metab., 284(2), E241-E258.10.1152/ajpendo.00408.200212531739
  10. Dahlman, I., Kaaman, M., Olsson, T., Tan, G.D., Bickerton, A.S., Wåhlén, K., Andersson, J., Nordström, E.A., Blomqvist, L., Sjögren, A., Forsgren, M., Attersand, A., Arner, P. (2005). A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects. J. Clin. Endocrinol. Metab., 90(10), 5834-5840.10.1210/jc.2005-036916091493
  11. Despres, J.P., Lemieux, I., Prud'homme, D. (2001). Treatment of obesity: need to focus on high risk abdominally obese patients. Brit. Med. J., 322, 716-720.10.1136/bmj.322.7288.716111990511264213
  12. Ezenwaka, C.E., Nwagbara, E., Seales, D., Okali, F., Sell, H., Eckel, J. (2009). Insulin resistance, leptin and monocyte chemotactic protein-1 levels in diabetic and non-diabetic Afro-Caribbean subjects. Arch. Physiol. Biochem., 115(1), 22-27.10.1080/1381345080267634319267279
  13. Haluzik, M. (2005). Adiponectin and its potential in the treatment of obesity, diabetes and insulin resistance. Curr. Opin. Investig. Drugs, 6 (10), 988-993.
  14. Herder, C., Baumert, J., Thorand, B., Koenig, W., de Jager, W., Meisinger, C., Illig, T., Martin, S., Kolb, H. (2006). Chemokines as risk factors for type 2 diabetes: Results from the MONICA/KORA Ausburg study, 1984-2002. Diabetologia, 49, 921-929.10.1007/s00125-006-0190-y16532324
  15. Ijzerman, R.G., Voordouw, J.J., van Weissenbruch, M.M., Yudkin, J.S., Serne, E.H., Delemarre-van de Waal, H.A., Stehouwer, C.D. (2006). TNF-alpha levels are associated with skin capillary recruitment in humans: a potential explanation for the relationship between TNF-alpha and insulin resistance. Clin. Sci. (Lond.), 110(3), 361-368.10.1042/CS2005031416316318
  16. Kasuga, M. (2006). Insulin resistance and pancreatic beta cell failure. J. Clin. Invest., 116, 1756-1760.10.1172/JCI29189148316416823472
  17. Kim, F., Gallis, B., Corson, M.A. (2001). TNF-{alpha} inhibits flow and insulin signaling leading to NO production in aortic endothelial cells. Amer. J. Physiol. Cell Physiol., 280(5), C1057-C1065.
  18. Kim, J.A., Montagnani, M., Koh, K.K., Quon, M.J. (2006). Reciprocal relationships between insulin resistance and endothelial dysfunction: Molecular and pathophysiological mechanisms. Circulation, 113(15), 1888-1904.10.1161/CIRCULATIONAHA.105.56321316618833
  19. Kissebah, A.H., Krakower, G.R. (1994). Regional adiposity and morbidity. Physiol. Rev., 74, 761-811.10.1152/physrev.1994.74.4.7617938225
  20. Kobashi, C., Urakaze, M., Kishida, M., Kibayashi, E., Kobayashi, H., Kihara, S., Funahashi, T., Takata, M., Temaru, R., Sato, A., Yamazaki, K., Nakamura, N., Kobayashi, M. (2005). Adiponectin inhibits endothelial synthesis of interleukin-8. Circ. Res., 97, 1245-1252.10.1161/01.RES.0000194328.57164.3616269654
  21. Mohamed, F., Monge, J.C., Gordon, A., Cernacek, P., Blais, D., Stewart, D.J. (1995). Lack of role for nitric oxide (NO) in the selective destabilization of endothelial NO synthase mRNA by tumor necrosis factor-alpha. Arterioscler. Thromb. Vasc. Biol., 15(1), 52-57.10.1161/01.ATV.15.1.527538424
  22. Moreau, M., Brocheriou, I., Petit, L., Ninio, E., Chapman, M.J., Rouis, M. (1999). Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macro-phages: Relevance to stability of atherosclerotic plaque. Circulation, 99, 420-426.10.1161/01.CIR.99.3.420
  23. Rask-Madsen, C., King, G.L. (2007). Mechanisms of disease: Endothelial dysfunction in insulin resistance and diabetes. Nat. Clin. Pract. Endocrinol. Metab., 3(1), 46-56.10.1038/ncpendmet036617179929
  24. Ravussin, E., Smith, S.R. (2002). Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann. N.Y. Acad. Sci., 967, 363-378.10.1111/j.1749-6632.2002.tb04292.x12079864
  25. Sartipy, P., Loskutoff, D.J. (2003). Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl. Acad. Sci. U.S.A., 100, 7265-7270.10.1073/pnas.113387010016586412756299
  26. Schaffler, A., Scholmerich, J., Buchler, C. (2005). Mechanisms of disease: Adipocytokines and visceral adipose tissue — emerging role in nonalcoholic fatty liver disease. Nat. Clin. Pract. Gastroenterol. Hepatol., 2(6), 273-280.10.1038/ncpgasthep018616265231
  27. Schinner, S., Kempf, K., Overmann, H., Willenberg, H.S., Schott, M., Rose, B., Scherbaum, W.A., Herder, C. (2008). Association of impaired glucose metabolism in morbid obesity with hypoadiponectinaemia. Exp. Clin. Endocrinol. Diabetes, 116 (Suppl 1), S64-S69.10.1055/s-2008-1081490
  28. Sell, H., Dietze-Schroeder, D., Kaiser, U., Eckel, J. (2006). Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle. Endocrinology, 147(5), 2458-2467.10.1210/en.2005-0969
  29. Serne, E.H., de Jongh, R.T., Eringa, E.C., Ijzerman, R.G., Stehouwer, C.D. (2007). Microvascular dysfunction: A potential pathophysiological role in the metabolic syndrome. Hypertension, 50(1), 204-211.10.1161/HYPERTENSIONAHA.107.089680
  30. Shin, W.S., Szuba, A., Rockson, S.G. (2002). The role of chemokines in human cardiovascular pathology: Enhanced biological insights. Atherosclerosis, 160, 91-102.10.1016/S0021-9150(01)00571-8
  31. Straczkowski, M., Dzienis-Straczkowska, S., Stepien, A., Kowalska, I., Szelachowska, M., Kinalska, I. (2002). Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system. J. Clin. Endocrinol. Metab., 87, 4602-4606.10.1210/jc.2002-02013512364441
  32. Turner, J., Belch, J.J., Khan, F. (2008). Current concepts in assessment of microvascular endothelial function using laser Doppler imaging and iontophoresis. Trends Cardiovasc. Med., 18(4), 109-116.10.1016/j.tcm.2008.02.00118555183
  33. Weisberg, S.P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K., Charo, I., Leibel, R.L., Ferrante, A.W. Jr. (2006). CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest., 116(1), 115-124.10.1172/JCI24335130755916341265
  34. Wellen, K.E., Hotamisligil, G.S. (2005). Inflammation, stress, and diabetes. J. Clin. Invest., 115(5), 1111-1119.10.1172/JCI25102108718515864338
  35. Wellen, K.E., Hotamisligil, G.S. (2003). Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest., 112, 1785-1788.10.1172/JCI2051429700614679172
  36. Williams, I.L., Wheatcroft, S.B., Shah, A.M., Kearney, M.T. (2002). Obesity, atherosclerosis and the vascular endothelium: Mechanisms of reduced nitric oxide bioavailability in obese humans. Int. J. Obes. Relat. Metab. Disord., 26(6), 754-764.10.1038/sj.ijo.080199512037644
  37. Yamauchi, T., Kadowaki, T. (2008). Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int. J. Obes. (Lond.), 32 (Suppl 7), S13-S18.10.1038/ijo.2008.23319136982
  38. Youd, J.M., Rattigan, S., Clark, M.G. (2000). Acute impairment of insulin-mediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by TNF-alpha. Diabetes, 49(11), 1904-1909.10.2337/diabetes.49.11.190411078458
  39. Zeng, G., Nystrom, F.H., Ravichandran, L.V., Cong, L.N., Kirby, M., Mostowski, H., Quon, M.J. (2000). Roles for insulin receptor, PI3-kinase, and Akt in insulin signalling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation, 101(13), 1539-1545.10.1161/01.CIR.101.13.1539
DOI: https://doi.org/10.2478/v10046-009-0051-4 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Language: English
Page range: 222 - 227
Published on: Nov 6, 2009
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2009 Pēteris Tretjakovs, Antra Jurka, Inga Bormane, Indra Miķelsone, Dace Reihmane, Līga Balode, Inta Jaunalksne, Vitolds Mackēvičs, Inga Stuķēna, Guntis Bahs, Aivars Lejnieks, Juris Aivars, Valdis Pīrāgs, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons License.

Volume 63 (2009): Issue 4-5 (October 2009)